Functional comparison of human-induced pluripotent stem cell-derived mesenchymal cells and bone marrow-derived mesenchymal stromal cells from the same donor

Stem Cells and Development

Volumn 23, Issue 14, 2014, Pages 1594-1610

  Diederichs, Solvig ^a,b   Tuan, Rocky S ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH DIFFERENTIATION FACTOR 3; OCTAMER TRANSCRIPTION FACTOR 4; ORGANIC CATION TRANSPORTER 3; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2;

ADIPOGENESIS; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; BONE MARROW DERIVED MESENCHYMAL STROMA CELL; CELL LINEAGE; CELL POPULATION; CELL STRUCTURE; CELLULAR, SUBCELLULAR AND MOLECULAR BIOLOGICAL PHENOMENA AND FUNCTIONS; CHONDROGENESIS; COCULTURE; COMPARATIVE STUDY; CONTROLLED STUDY; DONOR; DPPA5 GENE; FIBROBLAST; GENE; GENE EXPRESSION PROFILING; GROWTH DIFFERENTIATION FACTOR 3 GENE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; INDUCED PLURIPOTENT STEM CELL DERIVED MESENCHYMAL CELL; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STROMA CELL; METHODOLOGY; MIDDLE AGED; MOUSE; NANOG GENE; NONHUMAN; NORMAL HUMAN; NUCLEAR REPROGRAMMING; OCTAMER TRANSCRIPTION FACTOR 4 GENE; ORGANIC CATION TRANSPORTER 3 GENE; PLURIPOTENCY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; SOX2 GENE; TDGF GENE; TERATOMA; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOLOGY; GENETICS;

ADIPOGENESIS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MESENCHYMAL STROMAL CELLS; OSTEOGENESIS; TISSUE DONORS;

EID: 84904107750     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2013.0477     Document Type: Article

References (55)

1. Caplan AI and JE Dennis. (2006). Mesenchymal stem cells as trophic mediators. J Cell Biochem 98:1076-1084.
2. Nauta AJ and WE Fibbe. (2007). Immunomodulatory properties of mesenchymal stromal cells. Blood 110:3499-3506.
3. Bruder SP, N Jaiswal and SE Haynesworth. (1997). Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 64:278-294.
4. Stolzing A, E Jones, D McGonagle and A Scutt. (2008). Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev 129:163-173.
5. Bieback K and I Brinkmann. (2010). Mesenchymal stromal cells from human perinatal tissues: from biology to cell therapy. World J Stem Cells 2:81-92.
6. Guillot PV, C Gotherstrom, J Chan, H Kurata and NM Fisk. (2007). Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC. Stem Cells 25:646-654.
7. Wu SM and K Hochedlinger. (2011). Harnessing the potential of induced pluripotent stem cells for regenerative medicine. Nat Cell Biol 13:497-505.
8. Barberi T, LM Willis, ND Socci and L Studer. (2005). Derivation of multipotent mesenchymal precursors from human embryonic stem cells. PLoS Med 2:e161.
9. Lian Q, E Lye, K Suan Yeo, E Khia Way Tan, M Salto- Tellez, TM Liu, N Palanisamy, RM El Oakley, EH Lee, B Lim and SK Lim. (2007). Derivation of clinically compliant MSCs from CD105 + , CD24- differentiated human ESCs. Stem Cells 25:425-436.
10. Barbet R, I Peiffer, A Hatzfeld, P Charbord and JA Hatzfeld. (2011). Comparison of gene expression in human embryonic stem cells, hESC-derived mesenchymal stem cells and human mesenchymal stem cells. Stem Cells Int 2011:368192.
11. Lee EJ, HN Lee, HJ Kang, KH Kim, J Hur, HJ Cho, J Lee, HM Chung, J Cho, et al. (2010). Novel embryoid body-based method to derive mesenchymal stem cells from human embryonic stem cells. Tissue Eng Part A 16:705-715.
12. Karlsson C, K Emanuelsson, F Wessberg, K Kajic, MZ Axell, PS Eriksson, A Lindahl, J Hyllner and R Strehl. (2009). Human embryonic stem cell-derived mesenchymal progenitors-potential in regenerative medicine. Stem Cell Res 3:39-50.
13. Trivedi P and P Hematti. (2007). Simultaneous generation of CD34 + primitive hematopoietic cells and CD73 + mesenchymal stem cells from human embryonic stem cells cocultured with murine OP9 stromal cells. Exp Hematol 35:146-154.
14. Hwang NS, S Varghese, HJ Lee, Z Zhang, Z Ye, J Bae, L Cheng and J Elisseeff. (2008). In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells. Proc Natl Acad Sci U S A 105:20641-20646.
15. de Peppo GM, S Svensson, M Lenneras, J Synnergren, J Stenberg, R Strehl, J Hyllner, P Thomsen and C Karlsson. (2010). Human embryonic mesodermal progenitors highly resemble human mesenchymal stem cells and display high potential for tissue engineering applications. Tissue Eng Part A 16:2161-2182.
16. Olivier EN and EE Bouhassira. (2011). Differentiation of human embryonic stem cells into mesenchymal stem cells by the ''raclure'' method. Methods Mol Biol 690: 183-193.
17. Trivedi P and P Hematti. (2008). Derivation and immunological characterization of mesenchymal stromal cells from human embryonic stem cells. Exp Hematol 36:350-359.
18. Phinney DG, G Kopen, W Righter, S Webster, N Tremain and DJ Prockop. (1999). Donor variation in the growth properties and osteogenic potential of human marrow stromal cells. J Cell Biochem 75:424-436.
19. Pevsner-Fischer M, S Levin and D Zipori. (2011). The origins of mesenchymal stromal cell heterogeneity. Stem Cell Rev 7:560-568.
20. Deyle DR, IF Khan, G Ren, PR Wang, J Kho, U Schwarze and DW Russell. (2012). Normal collagen and bone production by gene-targeted human osteogenesis imperfecta iPSCs. Mol Ther 20:204-213.
21. Kuznetsov SA, N Cherman and PG Robey. (2011). In vivo bone formation by progeny of human embryonic stem cells. Stem Cells Dev 20:269-287.
22. Dominici M, K Le Blanc, I Mueller, I Slaper-Cortenbach, F Marini, D Krause, R Deans, A Keating, D Prockop and E Horwitz. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317.
23. Bourin P, BA Bunnell, L Casteilla, M Dominici, AJ Katz, KL March, H Redl, JP Rubin, K Yoshimura and JM Gimble. (2013). Stromal cells from the adipose tissuederived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: A joint statement of the International Federation for Adipose Therapeutics (IFATS) and Science and the International Society for Cellular Therapy (ISCT). Cytotherapy 15:641-648.
24. Yagi H, J Tan and RS Tuan. (2012). Polyphenols suppress hydrogen peroxide-induced oxidative stress in humanbone-marrow derived mesenchymal stem cells. J Cell Biochem 114:1163-1173.
25. Caterson EJ, LJ Nesti, KG Danielson and RS Tuan. (2002). Human marrow-derived mesenchymal progenitor cells: isolation, culture expansion, and analysis of differentiation. Mol Biotechnol 20:245-256.
26. Lin B, J Kim, Y Li, H Pan, X Carvajal-Vergara, G Salama, T Cheng, Y Li, CW Lo and L Yang. (2012). High-purity enrichment of functional cardiovascular cells from human iPS cells. Cardiovasc Res 95:327-335.
27. Takahashi K, K Tanabe, M Ohnuki, M Narita, T Ichisaka, K Tomoda and S Yamanaka. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-872.
28. Momcilovic O, L Knobloch, J Fornsaglio, S Varum, C Easley and G Schatten. (2010). DNA damage responses in human induced pluripotent stem cells and embryonic stem cells. PLoS One 5:e13410.
29. Teramura T, Y Onodera, T Mihara, Y Hosoi, C Hamanishi and K Fukuda. (2010). Induction of mesenchymal progenitor cells with chondrogenic property from mouse-induced pluripotent stem cells. Cell Reprogram 12:249-261.
30. Lin H, G Yang, J Tan and RS Tuan. (2012). Influence of decellularized matrix derived from human mesenchymal stem cells on their proliferation, migration and multi-lineage differentiation potential. Biomaterials 33:4480-4489.
31. Marolt D, IM Campos, S Bhumiratana, A Koren, P Petridis, G Zhang, PF Spitalnik, WL Grayson and G Vunjak-Novakovic. (2012). Engineering bone tissue from human embryonic stem cells. Proc Natl Acad Sci U S A 109:8705-8709.
32. Takahashi K and S Yamanaka. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676.
33. Sanchez L, I Gutierrez-Aranda, G Ligero, R Rubio, M Munoz-Lopez, JL Garcia-Perez, V Ramos, PJ Real, C Bueno, et al. (2011). Enrichment of human ESC-derived multipotent mesenchymal stem cells with immunosuppressive and anti-inflammatory properties capable to protect against experimental inflammatory bowel disease. Stem Cells 29:251-262.
34. Lian Q, Y Zhang, J Zhang, HK Zhang, X Wu, FF Lam, S Kang, JC Xia, WH Lai, et al. (2010). Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice. Circulation 121:1113-1123.
35. Olivier EN, AC Rybicki and EE Bouhassira. (2006). Differentiation of human embryonic stem cells into bipotent mesenchymal stem cells. Stem Cells 24:1914-1922.
36. Diederichs S, K Baral, M Tanner and W Richter. (2012). Interplay between local versus soluble transforming growth factor-beta and fibrin scaffolds: role of cells and impact on human mesenchymal stem cell chondrogenesis. Tissue Eng Part A 18:1140-1150.
37. Janicki P, S Boeuf, E Steck, M Egermann, P Kasten and W Richter. (2011). Prediction of in vivo bone forming potency of bone marrow-derived human mesenchymal stem cells. Eur Cell Mater 21:488-507.
38. Evans ND, RJ Swain, E Gentleman, MM Gentleman and MM Stevens. (2012). Gene-expression analysis reveals that embryonic stem cells cultured under osteogenic conditions produce mineral non-specifically compared to marrow stromal cells or osteoblasts. Eur Cell Mater 24:211-223.
39. Arpornmaeklong P, SE Brown, Z Wang and PH Krebsbach. (2009). Phenotypic characterization, osteoblastic differentiation, and bone regeneration capacity of human embryonic stem cell-derived mesenchymal stem cells. Stem Cells Dev 18:955-968.
40. Yen ML, CH Hou, KY Peng, PC Tseng, SS Jiang, CT Shun, YC Chen and ML Kuo. (2011). Efficient derivation and concise gene expression profiling of human embryonic stem cell-derived mesenchymal progenitors (EMPs). Cell Transplant 20:1529-1545.
41. Domev H, M Amit, I Laevsky, A Dar and J Itskovitz-Eldor. (2012). Efficient engineering of vascularized ectopic bone from human embryonic stem cell-derived mesenchymal stem cells. Tissue Eng Part A 18:2290-2302.
42. Chen YS, RA Pelekanos, RL Ellis, R Horne, EJ Wolvetang and NM Fisk. (2012). Small molecule mesengenic induction of human induced pluripotent stem cells to generate mesenchymal stem/stromal cells. Stem Cells Transl Med 1:83-95.
43. Lee EJ, HJ Kang, HN Lee, SK Kang, KH Kim, SW Lee, G Lee, YB Park and HS Kim. (2012). New culture system for human embryonic stem cells: autologous mesenchymal stem cell feeder without exogenous fibroblast growth factor 2. Differentiation 83:92-100.
44. Varga N, Z Vereb, E Rajnavolgyi, K Nemet, F Uher, B Sarkadi and A Apati. (2011). Mesenchymal stem cell like (MSCl) cells generated from human embryonic stem cells support pluripotent cell growth. Biochem Biophys Res Commun 414:474-480.
45. Villa-Diaz LG, SE Brown, Y Liu, AM Ross, J Lahann, JM Parent and PH Krebsbach. (2012). Derivation of mesenchymal stem cells from human induced pluripotent stem cells cultured on synthetic substrates. Stem Cells 30:1174-1181.
46. Boxall SA and E Jones. (2012). Markers for characterization of bone marrow multipotential stromal cells. Stem Cells Int 2012:975871.
47. Fujita H, M Yamamoto, T Ogino, H Kobuchi, N Ohmoto, E Aoyama, T Oka, T Nakanishi, K Inoue and J Sasaki. (2013). Necrotic and apoptotic cells serve as nuclei for calcification on osteoblastic differentiation of human mesenchymal stem cells in vitro. Cell Biochem Funct 32:77-86.
48. Nasu A, M Ikeya, T Yamamoto, A Watanabe, Y Jin, Y Matsumoto, K Hayakawa, N Amano, S Sato, et al. (2013). Genetically matched human iPS cells reveal that propensity for cartilage and bone differentiation differs with clones, not cell type of origin. PLoS One 8:e53771.
49. Yang SL, E Harnish, T Leeuw, U Dietz, E Batchelder, PS Wright, J Peppard, P August, C Volle-Challier, et al. (2012). Compound screening platform using human induced pluripotent stem cells to identify small molecules that promote chondrogenesis. Protein Cell 3:934-942.
50. Kattman SJ, AD Witty, M Gagliardi, NC Dubois, M Niapour, A Hotta, J Ellis and G Keller. (2011). Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell 8:228-240.
51. Nostro MC, X Cheng, GM Keller and P Gadue. (2008). Wnt, activin, and BMP signaling regulate distinct stages in the developmental pathway from embryonic stem cells to blood. Cell Stem Cell 2:60-71.
52. Kuhn LT, Y Liu, NL Boyd, J Dennis, X Jiang, X Xin, L Charles, L Wang, HL Aguila, et al. (2013). Developmentallike bone regeneration by human embryonic stem cellderived mesenchymal cells. Tissue Eng Part A 20:365-377.
53. Sze SK, DP de Kleijn, RC Lai, E Khia Way Tan, H Zhao, KS Yeo, TY Low, Q Lian, CN Lee, et al. (2007). Elucidating the secretion proteome of human embryonic stem cell-derived mesenchymal stem cells. Mol Cell Proteomics 6:1680-1689.
54. Evseenko D, Y Zhu, K Schenke-Layland, J Kuo, B Latour, S Ge, J Scholes, G Dravid, X Li, WR MacLellan and GM Crooks. (2010). Mapping the first stages of mesoderm commitment during differentiation of human embryonic stem cells. Proc Natl Acad Sci U S A 107:13742-13747.
55. Umeda K, J Zhao, P Simmons, E Stanley, A Elefanty and N Nakayama. (2012). Human chondrogenic paraxial mesoderm, directed specification and prospective isolation from pluripotent stem cells. Sci Rep 2:455.